Journals / Türk Anestezi ve Reanimasyon Dergisi / 2008 / Cilt: 36 - Sayı: 1

The effect of intraperitoneal ondansetron on intrathecal bupivacaine analgesic activity in the thermal pain model of rats

Ratlarda termal ağrı modelinde intratekal uygulanan bupivakainin analjezik etkisine intraperitoneal uygulanan ondansetronun etkisi

Pages
11–18
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Mean tail-flick values of Group B were significantly higher at each time compared to Group S (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study is to investigate the effect of systemic (intraperitoneally) two different doses ondansetron administration on analgesic activity of bupivacaine administered intrathecally in rats.Materials and Methods: 24 rats were included in the study.
📊
Key Findings & Data:Group Saline (Group S) (n=6): 10 µL of saline was administered intrathecally (IT) and 0.5 mL of saline was administered intraperitoneally.
💡
Conclusion & Impact:Results: Mean tail-flick values of Group B were significantly higher at each time compared to Group S (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study is to investigate the effect of systemic (intraperitoneally) two different doses ondansetron administration on analgesic activity of bupivacaine administered intrathecally in rats.Materials and Methods: 24 rats were included in the study. Group Saline (Group S) (n=6): 10 µL of saline was administered intrathecally (IT) and 0.5 mL of saline was administered intraperitoneally. Group Bupivacaine (Group B) (n=6): 10 µg 10 µL-1 of bupivacaine was administered IT and 0.5 mL of saline was administered intraperitoneally. Group Bupivacaine Ondansetron 1 (Group BO1) (n=6): 10 µg 10 µL-1 of bupivacaine was administered IT and 1 mg kg-1 ondansetron was administered intraperitoneally. Group Bupivacaine Ondansetron 4 (Group BO4) (n=6): 10 µg 10 µL-1 of bupivacaine was administered IT and 4 mg kg-1 ondansetron was administered intraperitoneally. Tail-flick test was applied to rats before and 5,10,20,30,45,60,90,120 minutes after drug administration. Data was showed as the percentage of maximum possible effect (%MPE). The presence of simultaneous motor block was evaluated with motor block evaluation scale. Results: Mean tail-flick values of Group B were significantly higher at each time compared to Group S (p

Özet

Amaç: Bu çalışmanın amacı ratlarda intratekal verilen bupivakainin analjezik etkisine sistemik (intraperitoneal) olarak uygulanan iki farklı doz ondansetronun etkisini araştırmaktır.Gereç ve Yöntem: Araştırmaya yirmi dört adet rat alındı. Grup Serum Fizyolojiğe (Grup SF) (n:6): 10 µL intratekal (‹T) SF+0.5 mL intraperitoneal (‹P) SF, Grup Bupivakain’e (Grup B) (n:6): 10 µg 10 µL-1 ‹T bupivakain + 0,5 mL ‹P SF, Grup Bupivakain Ondansetron 1’e (Grup BO1) (n:6): 10 µg 10 µL-1 ‹T bupivakain + 1 mg kg-1 ‹P ondansetron, Grup Bupivakain Ondansetron 4’e (Grup BO4) (n:6): 10 µg 10 µL-1 ‹T bupivakain + 4 mg kg-1 ‹P ondansetron verildi. ‹laç uygulamalarından önce (0. dk.) ve uygulamalardan sonra 5, 10, 20, 30, 45, 60, 90 ve 120. dk.’larda tail-flick testi uygulandı. Veriler maksimum olası etki yüzdesi olarak gösterildi (%MOE). Eş zamanlı motor blok varlığı motor blok değerlendirme skalası kullanılarak değerlendirildi. Bulgular: Grup SF ile Grup B karşılaştırıldığında; Grup B’de tail-flick ortalama değerleri tüm zamanlarda anlamlı, yüksek bulundu (p

🔖

Cite This Article

GÖKMEN, N., ÖZAY, R., ÖZKAYA, O., BALKAYA, H., YILMAZ, O., KÜÇÜKGÜÇLÜ, S. (2022). The effect of intraperitoneal ondansetron on intrathecal bupivacaine analgesic activity in the thermal pain model of rats. Türk Anestezi ve Reanimasyon Dergisi, Cilt: 36 - Sayı: 1, 11–18. https://ajindex.com/articles/620000

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Dickenson AH. Spinal cord pharmacology of pain. Br J Anaesth 1995; 75:193-200
  2. Lopez-Garcia JA. Serotonergic modulation of spinal sensory circuits. Curr Top Med Chem 2006; 6:1987-1996
  3. Naesh O, Hindberg I, Christiansen C. Subarachnoid bupivacaine increases human cerebrospinal fluid concentration of serotonin. Reg Anesth 1996; 21:446-450
  4. Petersen-Felix S, Arendt-Nielsen L, Bak P, Bjerring P, Breivik H, Svensson P, Zbinden AM. Ondansetron does not inhibit the analgesic effect of alfentanil. Br J Anaesth 1994; 73:326-330
  5. Glaum SR, Proudfit HK, Anderson EG. Reversal of the antinociceptive effects of intrathecally administered serotonin in the rat by a selective 5-HT3 receptor antagonist. Neurosci Lett 1988; 95:313-317
  6. Alhaider AA, Lei SZ, Wilcox GL. Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA. J Neurosci 1991; 11:1881-1888
  7. Ali Z, Wu G, Kozlov A, Barasi S. The role of 5HT3 in nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies. Neurosci Lett 1996; 208:203-207
  8. Erhan E, Onal A, Kocabas S, Yegül I. Ondansetron does not block Tramadol-induced Analgesia in Mice. Methods Find Exp Clin Pharmacol 2005; 27:629-632 9. Hunt TE, Wu W, Zbuzej VK. Ondansetron blocks nifedipine-›nduced analgesia in rats. Anesth Analg 1996; 82:498-500
  9. De Witte JL, Schoenmaekers B, Sesler DI, Deloof T. The analgesic efficacy of tramadol is impaired by concurrent administration of ondansetron. Anesth Analg 2001; 92:1319-1321
  10. Arcioni R, della Rocca M, Romano S, Romano R, Pietropaoli P, Gasparetto A. Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT(3) spinal receptor involvement in acute pain in humans. Anesth Analg 2002; 94:1553-1557
  11. Fassoulaki A, Melemeni A, Zotou M, Sarantopoulos C. Systemic ondansetron antagonizes the sensory block produced by intrathecal lidocaine. Anesth Analg 2005; 100:1817-1821
  12. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiology Behavior 1976; 17:1031-1036
  13. Korkmaz HA, Maltepe F, Erbayraktar S, Y›lmaz O, et al. Antinociceptive and neurotoxicologic screening of chronic intrathecal administration of ketorolac tromethamine in the rat. Anesth Analg 2004; 98:148-152
  14. Sakura S, Kirihara Y, Muguruma T, Kishimoto T, Saito Y. The comparative neurotoxicity of intrathecal lidocaine and bupivacaine in rats. Anesth Analg 2005; 101:541-547
  15. Nishiyama T, Hanaoka K. Intrathecal clonidine an